Chemical Compound Review:
Cilazaprilat (5S,8S)-5-[[(1S)-1-carboxy-3- phenyl...
Synonyms:
Cilazaprilate, Cilazaprilatum, SureCN906169, AG-H-69240, CHEMBL2104578, ...
- Cardioprotective effect of angiotensin-converting enzyme inhibition against hypoxia/reoxygenation injury in cultured rat cardiac myocytes. Matoba, S., Tatsumi, T., Keira, N., Kawahara, A., Akashi, K., Kobara, M., Asayama, J., Nakagawa, M. Circulation (1999)
- Role of Ca2+-activated K+ channels in the protective effect of ACE inhibition against ischemic myocardial injury. Node, K., Kitakaze, M., Kosaka, H., Minamino, T., Mori, H., Hori, M. Hypertension (1998)
- Effects of cilazaprilat and enalaprilat on experimental dermatitis in guinea pigs. Rosenqvist, U., Persson, K., Lindgren, B.R., Andersson, R.G. Pharmacol. Toxicol. (1991)
- Local angiotensin II generation in the rat heart: role of renin uptake. Müller, D.N., Fischli, W., Clozel, J.P., Hilgers, K.F., Bohlender, J., Ménard, J., Busjahn, A., Ganten, D., Luft, F.C. Circ. Res. (1998)
- Potentiation of endothelium-dependent relaxations to bradykinin by angiotensin I converting enzyme inhibitors in canine coronary artery involves both endothelium-derived relaxing and hyperpolarizing factors. Mombouli, J.V., Illiano, S., Nagao, T., Scott-Burden, T., Vanhoutte, P.M. Circ. Res. (1992)
- Endothelium-modulated proliferation of medial smooth muscle cells: influence of angiotensin II and converting enzyme inhibition. Hahn, A.W., Schmidt, R., Kern, F., Resink, T.J., Bühler, F.R. Eur. Heart J. (1995)
- Effects of the converting enzyme inhibitor cilazaprilat on endothelium-dependent responses. Mombouli, J.V., Nephtali, M., Vanhoutte, P.M. Hypertension (1991)
- In vivo visualization of subendocardial arteriolar response in renovascular hypertensive hearts. Yada, T., Goto, M., Hiramatsu, O., Tachibana, H., Toyota, E., Nakamoto, H., Ogasawara, Y., Matsuda, H., Arakawa, K., Hayashi, K., Suzuki, H., Kajiya, F. Am. J. Physiol. Heart Circ. Physiol. (2003)
- Effects of ACE-inhibition on redox status and expression of P-selectin of endothelial cells subjected to oxidative stress. Zahler, S., Kupatt, C., Möbert, J., Becker, B.F., Gerlach, E. J. Mol. Cell. Cardiol. (1997)
- A pharmacokinetic study of cilazapril in elderly and young volunteers. Williams, P.E., Brown, A.N., Rajaguru, S., Walters, G.E., McEwen, J., Durnin, C. British journal of clinical pharmacology. (1989)
- The effect of acute ACE inhibition on atrial natriuretic peptide. Doorenbos, C.J., van Brummelen, P. British journal of clinical pharmacology. (1989)
- Variation in angiotensin-converting enzyme (ACE) inhibitor affinity at two binding sites on rat pulmonary ACE: influence on bradykinin hydrolysis. Perich, R.B., Jackson, B., Johnston, C.I. Clin. Exp. Pharmacol. Physiol. (1992)
- Cellular mechanisms of cardioprotection afforded by inhibitors of angiotensin converting enzyme in ischemic hearts: role of bradykinin and nitric oxide. Kitakaze, M., Node, K., Takashima, S., Minamino, T., Kuzuya, T., Hori, M. Hypertens. Res. (2000)
- In vitro effect of cilazaprilat on sodium-potassium transport systems in human erythrocytes. Lijnen, P. Methods and findings in experimental and clinical pharmacology. (1990)
- Enalaprilat, but not cilazaprilat, increases inflammatory skin reactions in guinea-pigs. Andersson, R.G., Karlberg, B.E., Lindgren, B.R., Persson, K., Rosenqvist, U. Drugs (1991)
- Cilazapril. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in cardiovascular disease. Deget, F., Brogden, R.N. Drugs (1991)
- The pharmacokinetics and bioavailability of cilazapril in normal man. Williams, P.E., Brown, A.N., Rajaguru, S., Francis, R.J., Walters, G.E., McEwen, J., Durnin, C. British journal of clinical pharmacology. (1989)
- Cilazapril and enalapril inhibit local angiotensin I conversion in human veins but lack direct venodilating properties. Eichler, H.G., Blöchl-Daum, B., Kyrle, P.A., Gasic, S. J. Cardiovasc. Pharmacol. (1989)
- A review of the preclinical cardiovascular pharmacology of cilazapril, a new angiotensin converting enzyme inhibitor. Waterfall, J.F. British journal of clinical pharmacology. (1989)
- Beneficial effects of inhibition of angiotensin-converting enzyme on ischemic myocardium during coronary hypoperfusion in dogs. Kitakaze, M., Minamino, T., Node, K., Komamura, K., Shinozaki, Y., Mori, H., Kosaka, H., Inoue, M., Hori, M., Kamada, T. Circulation (1995)
- Steady-state pharmacokinetics and pharmacodynamics of cilazapril in the presence and absence of cyclopenthiazide. Krum, H., Jackson, B., Conway, E.L., Howes, L.G., Johnston, C.I., Louis, W.J. J. Cardiovasc. Pharmacol. (1992)
- Quantitative determination of the angiotensin-converting enzyme inhibitor cilazapril and its active metabolite cilazaprilat in pharmaceuticals and urine by high-performance liquid chromatography with amperometric detection. Prieto, J.A., Jiménez, R.M., Alonso, R.M. J. Chromatogr. B Biomed. Sci. Appl. (1998)